Sanofi Consumer Healthcare India Ltd held its AGM on June 26, 2026, with shareholders approving all six resolutions. A final dividend of Rs 75 per equity share was approved, but a significant portion of institutional investors opposed the auditor appointment.
Sanofi Consumer Healthcare India Ltd: AGM Approves Resolutions, Declares Rs 75 Dividend
Shareholders approve all six resolutions at the 3rd Annual General Meeting held on June 26, 2026. A final dividend of Rs 75 per equity share for FY 2025 is approved.
Reader Takeaway: Continuity assured via resolutions; institutional dissent on auditor appointment warrants tracking.
What just happened
Sanofi Consumer Healthcare India Limited conducted its 3rd Annual General Meeting (AGM) on June 26, 2026. All six resolutions put forth to the shareholders were successfully passed. These included the adoption of financial statements and the declaration of a final dividend.
Why this matters
The approval of all resolutions signifies continued shareholder confidence and allows the company to proceed with its financial and governance plans. The approved final dividend of Rs 75 per equity share provides a direct return to shareholders. However, a notable aspect was the dissent from institutional investors on the appointment of statutory auditors.
The backstory
Sanofi Consumer Healthcare India Limited operates within the pharmaceutical and healthcare sector, focusing on consumer health products. The company regularly convenes AGMs to ensure transparent governance and shareholder participation in key decisions.
What changes now
With all resolutions passed, the company will proceed with the declared dividend payout and the appointment of M/s. Price Waterhouse & Co Chartered Accountants LLP as its statutory auditors. The company now moves forward with its operational and financial plans for the upcoming period.
Risks to watch
While all resolutions passed, the significant opposition from public institutions (approximately 42.7% of votes polled by this category) to the appointment of statutory auditors (Resolution 4) is a governance watch point. Investors should monitor future communications to understand the rationale behind this dissent and how the company addresses it.
Peer comparison
General AGMs for listed companies typically involve routine approvals. However, the specific voting outcome on auditor appointments can sometimes reflect deeper shareholder concerns about audit quality or governance practices, which might differ across peers.
Context metrics (time-bound)
- Total Shareholders (Record Date): 49,698 as of June 19, 2026.
- Final Dividend FY 2025: Rs 75 per equity share.
- Votes Against (Resolution 4): 1,799,951 votes polled against the statutory auditor appointment.
What to track next
Investors should keep an eye on subsequent company disclosures and management commentary for insights into the institutional investors' concerns regarding the auditor appointment. Tracking future audit committee reports and any changes in auditor relationship policies will be important.